FGK Clinical Research

Executive Summary

FGK Clinical Research GmbH is a full-service Contract Research Organization (CRO) headquartered in Munich, Germany, with over three decades of experience since its founding in 1990. The company differentiates itself through a flexible, owner-driven approach, providing tailored clinical development and consulting services to pharmaceutical, biotechnology, and medical device firms. By employing dedicated small teams, FGK navigates the complexities of clinical studies efficiently, emphasizing personalized service and operational agility. As a private entity with no disclosed funding or valuation, FGK maintains a stable, low-profile presence in the competitive CRO landscape, focusing on European clients and leveraging its deep expertise in clinical trial management. The company's sustainable business model and long-standing reputation position it as a reliable partner for mid-sized and large biopharma companies seeking customized clinical solutions without the overhead of larger CROs.

Upcoming Catalysts (preview)

• Q3 2026Expansion into Asian or North American markets through strategic partnerships or new office openings60% success
• Q4 2026Launch of decentralized clinical trial (DCT) capabilities or digital health platform to enhance remote monitoring70% success
• TBDMajor contract win with a top 20 pharmaceutical company for a late-stage oncology or rare disease program50% success